Search the Newsreel

Somnigroup Announces Third Quarter Cash Dividend

DALLAS, Aug. 6, 2026 /PRNewswire/ -- Somnigroup International Inc. (NYSE: SGI, "Company" or "Somnigroup") today announced that its Board of Directors has declared a third quarter cash dividend on its common stock of $0.17 per share. The dividend is payable on September 3, 2026, …

Vuzix (VUZI) Expected to Announce Quarterly Earnings on Thursday

Vuzix (NASDAQ:VUZI) is set to announce its Q2 2026 earnings on Thursday, August 13th, with analysts anticipating a loss of ($0.11) per share and revenue of $1.5020 million. The company previously beat analyst estimates in Q1, reporting ($0.09) EPS on $1.39 million in revenue. …

Omnitech Engineering share price tumbles 14% after Q1 results

Somnigroup International (SGI) Earnings Date and Reports 2026 $SGI

AMN Healthcare search revenue grew 27% after Q2 results exceeded guidance

AMN Healthcare Services (AMN) Earnings Date and Reports 2026

OmniAb (OABI) Earnings Date and Reports 2026

OmniAb Inc (OABI) Earnings Forecast: Future EPS & Revenue Growth Estimates

MNTN, Inc.: Cash Flow Finally Catches Up With Earnings (NYSE:MNTN)

Omnicom Group Inc. (NYSE:OMC) Given Consensus Rating of "Hold" by Analysts

Eleven analysts have given Omnicom Group Inc. (NYSE:OMC) a consensus "Hold" rating, with an average 12-month price target of $99, significantly higher than its recent share price of $81.76. The company recently reported Q2 earnings per share of $2.65, slightly missing estimates, but revenue …

Somnigroup International (SGI) Refinances Term Loans Ahead Of Planned Acquisition

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Somnigroup International (NYSE: SGI) amended its credit agreement and refinanced term loans in connection with its anticipated acquisition of Leggett & Platt. The amended facilities …

Earnings Flash (AMN) AMN Healthcare Services, Inc. Posts Q2 Adjusted EPS $0.77 per Share, vs. FactSet Est of $0.19

AMN Healthcare Services, Inc. (AMN) announced its Q2 adjusted EPS of $0.77 per share, significantly surpassing the FactSet estimate of $0.19. The company also reported Q2 revenue of $673.2 million, exceeding the FactSet estimate of $628.4 million, and provided Q3 revenue guidance ranging from …

Global Indemnity Group, LLC Crushes Q2 2026 Profit Estimates by 20.6%

AMN Healthcare Services (AMN) Q2 Earnings Report Preview: What To Look For

AMN Healthcare Services (NYSE:AMN) is set to release its Q2 earnings report this Thursday after market close. Analysts anticipate a 4.5% year-on-year revenue decline, an improvement from the 11.1% decrease in the same quarter last year. The company has a history of exceeding Wall …

Transcript : Global Indemnity Group, LLC, Q2 2026 Earnings Call, Aug 05, 2026

This article provides the transcript of Global Indemnity Group, LLC's Q2 2026 earnings call, which took place on August 5, 2026. The call began with a message from the operator, but the rest of the transcript is reserved for subscribers. The page also lists …

Truist Financial Maintains AMN Healthcare Services(AMN.US) With Buy Rating

Truist Financial has reiterated its Buy rating on AMN Healthcare Services (AMN.US). The firm also maintained its price target of $105.00 for the company.

Omnicell, Inc. (NASDAQ: OMCL) returns to profit with Q2 2026 growth

OMNICELL, INC. 2026: Revenue $312.21M, EPS $0.52— 10-Q Summary

Omnicell, Inc. (OMCL) reported strong financial results for the quarter ended 2026, with revenue reaching $312.21M and diluted EPS of $0.52. This growth was driven by increased product and service sales, improved margins, and strategic shifts towards platform offerings and recurring revenue. The company …

Global Indemnity Group Q2 2026 Earnings Call Transcript

Global Indemnity Group (GBLI) reported strong Q2 2026 earnings with an accident-year combined ratio of 94.7% and $5.8 million in underwriting income. The company saw 7% year-over-year growth in Belmont Core gross written premiums and expects approximately 15% full-year premium growth, with investment income …

Earnings call transcript: Global Indemnity beats revenue in Q2 2026 as stock rises

Global Indemnity Group (GBLI) reported strong Q2 2026 earnings with an accident-year combined ratio of 94.7% and $5.8 million in underwriting income. The company saw 7% year-over-year growth in Belmont Core gross written premiums and expects approximately 15% full-year premium growth, with investment income …

ETFs Investing in Global Indemnity Group LLC Class A Stocks

This article lists ETFs that invest in Global Indemnity Group LLC Class A stocks. It provides a table showing funds, their market value, weight in the fund, issuer, management style, expense ratio, AUM, price, change percentage, relative volume, and 3-year NAV total return. The …

Global Indemnity Group, LLC Reports Financial Results for the three and six months ended June 30, 2026

Global Indemnity Group, LLC reported increased net income for both the three and six months ended June 30, 2026, with quarterly net income rising 8% to $11.1 million, or $0.76 per share. The company saw a 7% growth in Belmont Core gross written premiums …

Omnicom Media Exec at Beet Retreat Discusses AI’s Influence Across Ad Industry

Ominicom's Joanna O'Connell joins NYSE Live to discuss AI and the Ad industry View Comments

MNTN, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:MNTN) 2026-08-05

Global Indemnity Q2 Net Income Rises to $11.1 Million

Global Indemnity Group (GBLI) reported a rise in second-quarter net income to $11.1 million, or $0.76 per share, up from $10.3 million a year prior. Total revenues for the quarter were $116.1 million. The company also saw increased net income and diluted EPS for …

Omnicom

Omnicom Group, Inc. (OMC) is a New York-based holding company offering advertising, marketing, and corporate communications services. As of August 5, 2026, its stock price was $81.71, with a market capitalization of $22.42 billion. The article provides a detailed financial summary from 2011 to …

MNTN: Accelerating Growth, Expanding Margins Prompt Laura Martin to Reiterate Buy Rating and $18 Price Target

Needham analyst Laura Martin reiterated a Buy rating and an $18 price target for MNTN, Inc Class A, citing the company's accelerating top-line growth and expanding margins. MNTN reported 21% year-over-year revenue growth in Q2 2026, alongside a 48% increase in adjusted EBITDA, driven …

Earnings To Watch: OmniAb Inc (OABI) Q2 2026 -- GF Value Sees 54% Upside

MNTN Q2 Earnings Call Highlights

MNTN: Q2 2026 delivered 21% revenue growth, 80% gross margin, and $6.7M net income

MNTN, Inc. (NYSE: MNTN) swings to Q2 profit and authorizes $100M repurchase

Omnicom Group Inc. stock underperforms Tuesday when compared to competitors despite daily gains

Omnicom Group Inc. (OMC) stock gained 3.20% on Tuesday, closing at $81.81, despite the broader market also seeing positive performance. The S&P 500 Index rose 1.79%, and the Dow Jones Industrial Average increased by 1.71%. This marks the second consecutive day of gains for …

MMC Introduces a New AI Methodology for Understanding Culture

NEW YORK, Aug. 4, 2026 /PRNewswire/ -- MMC, an Omnicom Public Relations agency, today introduced a new methodology for understanding culture, designed to identify emerging shifts before they become conventional wisdom and translate them into strategic communications insight. The methodology is brought to life …

Erie Indemnity CFO Julie Pelkowski Reports 401(k) Stock Purchase and Deferral Plan Holdings

Julie Marie Pelkowski, Executive Vice President and Chief Financial Officer of Erie Indemnity Co (NASDAQ: ERIE), filed a Form 4 on August 3, 2026. This report details a change in beneficial ownership of Class A Common Stock, dated July 31, 2026. The article focuses …

Precision Trading with Global Indemnity Group Llc Class A (de) (GBLI) Risk Zones

This article provides a detailed analysis of Global Indemnity Group Llc Class A (de) (GBLI) using AI-generated signals for precision trading. It highlights a strong near-term sentiment but a neutral mid- and long-term outlook, identifying a 17.6:1 risk-reward short setup. The analysis includes specific …

UBS raises Amneal Pharmaceuticals price target on biosimilar growth

UBS has increased its price target for Amneal Pharmaceuticals Inc. to $25.00 from $23.00, maintaining a Buy rating. This adjustment follows the company's strong second-quarter earnings beat and raised guidance, despite a recent stock pullback. UBS anticipates significant growth from Amneal's biosimilar and generic …